Natixis Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-37,375
| Closed | -$565K | – | 1534 |
|
|
2022
Q3 | $565K | Buy |
37,375
+183
| +0.5% | +$2.77K | ﹤0.01% | 1253 |
|
|
2022
Q2 | $279K | Sell |
37,192
-220
| -0.6% | -$1.65K | ﹤0.01% | 1398 |
|
|
2022
Q1 | $340K | Buy |
+37,412
| New | +$340K | ﹤0.01% | 1355 |
|
|
2021
Q4 | – | Sell |
-23,803
| Closed | -$271K | – | 1392 |
|
|
2021
Q3 | $271K | Sell |
23,803
-259
| -1% | -$2.95K | ﹤0.01% | 1284 |
|
|
2021
Q2 | $385K | Sell |
24,062
-385
| -2% | -$6.16K | ﹤0.01% | 1246 |
|
|
2021
Q1 | $436K | Sell |
24,447
-1,292
| -5% | -$23K | ﹤0.01% | 1184 |
|
|
2020
Q4 | $348K | Buy |
+25,739
| New | +$348K | ﹤0.01% | 1161 |
|